Axsome Therapeutics (AXSM) stock falls as its depression drug solriamfetol fails in a Phase 3 trial for those with daytime sleepiness. Read more here.

Eating four or more servings of ultra-processed food daily increases the risk of depression by 10% in older adults and ...

A new study found that over half of US adults experienced some form of discrimination, and individuals with high exposure to discrimination have more than five times the chances of screening positive ...

Why: Depression is common in late life, effecting nearly five million of the 31 million Americans aged 65 and older. Both major and minor depression are reported in 13% of community dwelling older ...

People with certain dark personality traits may be more likely to experience symptoms of depression, according to a new study ...

Depression affects about one in 20 adults, and while treatments like antidepressants and talk therapy help many people, they ...

Lipocine Inc. (NASDAQ: LPCN), a biopharmaceutical company leveraging its proprietary technology platform to enable effective oral delivery of therapeutics, today announced the initiation of a Phase 3 ...

The University of Athens (EKPA) has created the first, global test specifically designed to measure addiction to the Tik Tok ...

BlackRock's recently posted CEO Larry Fink’s 2025 Annual Chairman’s Letter to Investors. Click here to read the full fund ...

A growing body of research has drawn connections between everyday discrimination—the routine and often subtle forms of ...

Discover the 6 key aspects of ADHD that help parents understand symptoms, diagnosis, and support options to ensure children ...